Abhasnee Sobhonslidsuk

2.5k total citations
66 papers, 1.1k citations indexed

About

Abhasnee Sobhonslidsuk is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Abhasnee Sobhonslidsuk has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 49 papers in Hepatology and 19 papers in Surgery. Recurrent topics in Abhasnee Sobhonslidsuk's work include Liver Disease Diagnosis and Treatment (46 papers), Liver Disease and Transplantation (25 papers) and Hepatitis B Virus Studies (15 papers). Abhasnee Sobhonslidsuk is often cited by papers focused on Liver Disease Diagnosis and Treatment (46 papers), Liver Disease and Transplantation (25 papers) and Hepatitis B Virus Studies (15 papers). Abhasnee Sobhonslidsuk collaborates with scholars based in Thailand, United States and Japan. Abhasnee Sobhonslidsuk's co-authors include K. Rajender Reddy, Ammarin Thakkinstian, Sasivimol Rattanasiri, Chulaporn Roongpisuthipong, Sriwatana Songchitsomboon, Kanokrat Nantiruj, Noriyo Yamashiki, Thunyarat Anothaisintawee, Wasana Stitchantrakul and Yot Teerawattananon and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Abhasnee Sobhonslidsuk

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abhasnee Sobhonslidsuk Thailand 21 652 557 253 162 117 66 1.1k
Sunil Taneja India 20 904 1.4× 950 1.7× 409 1.6× 144 0.9× 141 1.2× 181 1.6k
Joanna Raszeja‐Wyszomirska Poland 20 626 1.0× 564 1.0× 320 1.3× 123 0.8× 45 0.4× 87 1.1k
Madhumita Premkumar India 25 952 1.5× 963 1.7× 407 1.6× 120 0.7× 157 1.3× 154 1.7k
Stanley M. Cohen United States 17 776 1.2× 647 1.2× 350 1.4× 68 0.4× 148 1.3× 66 1.5k
Mithun Sharma India 21 654 1.0× 506 0.9× 361 1.4× 60 0.4× 117 1.0× 90 1.2k
Arka De India 15 699 1.1× 461 0.8× 178 0.7× 181 1.1× 74 0.6× 110 1.0k
Michelle M. Richardson United States 12 673 1.0× 571 1.0× 299 1.2× 67 0.4× 42 0.4× 31 1.3k
Neeral L. Shah United States 20 843 1.3× 949 1.7× 454 1.8× 73 0.5× 84 0.7× 55 1.5k
Avik Majumdar Australia 17 584 0.9× 651 1.2× 330 1.3× 93 0.6× 54 0.5× 84 973
Banwari Agarwal United Kingdom 20 796 1.2× 964 1.7× 491 1.9× 202 1.2× 266 2.3× 62 1.5k

Countries citing papers authored by Abhasnee Sobhonslidsuk

Since Specialization
Citations

This map shows the geographic impact of Abhasnee Sobhonslidsuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhasnee Sobhonslidsuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhasnee Sobhonslidsuk more than expected).

Fields of papers citing papers by Abhasnee Sobhonslidsuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abhasnee Sobhonslidsuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhasnee Sobhonslidsuk. The network helps show where Abhasnee Sobhonslidsuk may publish in the future.

Co-authorship network of co-authors of Abhasnee Sobhonslidsuk

This figure shows the co-authorship network connecting the top 25 collaborators of Abhasnee Sobhonslidsuk. A scholar is included among the top collaborators of Abhasnee Sobhonslidsuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abhasnee Sobhonslidsuk. Abhasnee Sobhonslidsuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sobhonslidsuk, Abhasnee, et al.. (2024). Hemoglobin and total bilirubin may affect tacrolimus clearance in liver transplant patient following the early postoperative period: a case report. Journal of Medical Case Reports. 18(1). 408–408. 1 indexed citations
2.
Bagepally, Bhavani Shankara, Abhasnee Sobhonslidsuk, M D Gupte, et al.. (2024). Cost-effective analysis of hepatitis A vaccination in Kerala state, India. PLoS ONE. 19(6). e0306293–e0306293. 3 indexed citations
3.
Puangpetch, Apichaya, Sissades Tongsima, Pornpen Srisawasdi, et al.. (2024). Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus. World Journal of Hepatology. 16(3). 366–378. 3 indexed citations
4.
Chirapongsathorn, Sakkarin, Wattana Sukeepaisarnjaroen, Sombat Treeprasertsuk, et al.. (2022). Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 6 indexed citations
5.
Angkathunyakul, Napat, et al.. (2021). Diffuse gallbladder wall thickening in autoimmune hepatitis: an unusual presentation. BMJ Case Reports. 14(5). e241325–e241325. 1 indexed citations
6.
Charatcharoenwitthaya, Phunchai, Piyawat Komolmit, Wattana Sukeepaisarnjaroen, et al.. (2020). Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study. BMC Gastroenterology. 20(1). 47–47. 20 indexed citations
7.
Thakkinstian, Ammarin, et al.. (2020). Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam. Value in Health. 23(9). 1180–1190. 10 indexed citations
8.
Chaikledkaew, Usa, et al.. (2019). Systematic Review with Meta-Analysis: Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C Genotypes 5 and 6. BioMed Research International. 2019. 1–12. 3 indexed citations
9.
Sripongpun, Pimsiri, Pisit Tangkijvanich, Watcharasak Chotiyaputta, et al.. (2019). Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients. JGH Open. 4(1). 69–74. 5 indexed citations
10.
Yamashiki, Noriyo, et al.. (2019). Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis. BMC Gastroenterology. 19(1). 150–150. 67 indexed citations
11.
Anothaisintawee, Thunyarat, et al.. (2018). Clinical Outcomes after Liver Transplantation for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis. BioMed Research International. 2018. 1–8. 19 indexed citations
12.
Sobhonslidsuk, Abhasnee, et al.. (2018). The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais. BioMed Research International. 2018. 1–8. 59 indexed citations
13.
Sobhonslidsuk, Abhasnee, et al.. (2017). Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Chronic Hepatitis B. BioMed Research International. 2017. 1–8. 1 indexed citations
14.
Rattanasiri, Sasivimol, et al.. (2017). The detection of hepatocellular carcinoma (HCC) from patients’ breath using canine scent detection: a proof-of-concept study. Journal of Breath Research. 11(4). 46002–46002. 11 indexed citations
15.
Sobhonslidsuk, Abhasnee, et al.. (2016). Nucleotide Analogue-Related Proximal Renal Tubular Dysfunction during Long-Term Treatment of Chronic Hepatitis B: A Cross-Sectional Study. Gastroenterology Research and Practice. 2016. 1–7. 3 indexed citations
16.
Sobhonslidsuk, Abhasnee, et al.. (2016). 809 Reversal of Proximal Renal Tubular Dysfunction After Nucleotide Analogue Withdrawal in Chronic Hepatitis B. Gastroenterology. 150(4). S1048–S1049. 1 indexed citations
17.
Thakkinstian, Ammarin, et al.. (2015). A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury. BMC Complementary and Alternative Medicine. 15(1). 334–334. 63 indexed citations
18.
Sobhonslidsuk, Abhasnee, et al.. (2015). Non-alcoholic Fatty Liver Disease (NAFLD) and Significant Hepatic Fibrosis Defined by Non-invasive Assessment in Patients with Type 2 Diabetes. Asian Pacific Journal of Cancer Prevention. 16(5). 1789–1794. 23 indexed citations
19.
Sobhonslidsuk, Abhasnee, et al.. (2009). Improving quality of colonoscopy by adding simethicone to sodium phosphate bowel preparation. World Journal of Gastroenterology. 15(24). 3032–3032. 49 indexed citations
20.
Sobhonslidsuk, Abhasnee, Lennox J. Jeffers, Juan R. Madariaga, et al.. (2005). Budd–Chiari‐like presentation of hepatic adenoma. Journal of Gastroenterology and Hepatology. 20(4). 653–656. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026